Gastar Exploration Limited (USA) (AMEX:GST) was one of the top percentage gainer and surged 51.0% and closed at near to its highest point of the day at $0.58 on an unusual volume of 14.15 million shares. Today, Gastar Exploration Ltd. announced that it has entered into definitive agreements with Santos QNT Pty Ltd and Santos International Holdings Pty Ltd for the sale of all of Gastar’s interest in Petroleum Exploration Licenses 238, 433 and 434 in New South Wales, Australia, along with the sale of the shares of Gastar Power Pty Ltd. Gastar Exploration Ltd. is an independent energy company engaged in the exploration, development and production of natural gas and oil in the United States and Australia. The Company’s principal business activities include the identification, acquisition, and exploration and development of natural gas and oil properties. Its emphasis is on prospective deep structures identified through seismic and other analytical techniques, as well as unconventional natural gas reserves, such as coal bed methane (CBM).

Northgate Minerals Corporation (USA) (AMEX:NXG) closed at $2.20, jumped over 1.4% on 2.75 million shares. Today, Northgate Minerals Corporation and the Matachewan First Nation announced that the parties have signed an Impact and Benefits Agreement (IBA) for the Young Davidson project located in Matachewan, Ontario. Northgate Minerals Corporation is a Canadian-based gold and copper producer with operations, development projects and exploration properties in Canada and Australia. The Corporation’s principal producing assets are its 100% interests in the Fosterville and Stawell Gold mines in Australia and the Kemess South mine in Canada. The Corporation also holds a 100% interest in the Young-Davidson property, a development project in Canada. The Company’s properties include Kemess, Young-Davidson, Fosterville, Stawell, Matachewan Mineral Property and Boulevard Property.

ADVENTRX Pharmaceuticals, Inc (AMEX:ANX) moved up over 6.4% and closed at near to its highest point of the day at $0.149 on a thinly traded volume of 1.72 million shares. Over the last month the stock has gained nearly 22.03%.ADVENTRX Pharmaceuticals, Inc is a development-stage biopharmaceutical company. The Company’s business is focused on in-licensing, developing and commercializing product candidates for the treatment of cancer. Its lead product candidates, ANX-530 and ANX-514, are emulsion formulations of marketed chemotherapy drugs.

Penny Stock Pick Alert alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, hot penny stocks with buy signals and companies with news. Our penny stock newsletter is well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%. We encourage investors to join our FREE e-mail alerts by visiting Penny Stock Pick Alert

Posted on Friday, July 3rd, 2009 at 3:55 pm and is filed under Energy Companies, energy investment.
Tags: Acquisition, ADVENTRX Pharmaceuticals, Australia, biopharmaceutical, Canada, cancer, chemotherapy, copper producer, energy, Fosterville, gas and oil, gas and oil properties, Gastar Exploration Limited, Gastar Exploration Ltd, Gastar Power Pty Ltd., gold and copper producer, Inc., Kemess South mine, Matachewan, New South Wales, Northgate Minerals Corporation, Ontario, Partnership, Penny Stock Pick Alert, Petroleum Exploration Licenses 238, principal business activities, Santos International Holdings Pty Ltd, Santos QNT Pty Ltd, treatment of cancer, unconventional natural gas reserves, United States, USD.